Access to this article is restricted until 12 months after publication by request of the publisher.. Restriction lift date: 2020-02-05
Self-assembled cationic β-cyclodextrin nanostructures for siRNA delivery
No Thumbnail Available
Files
Accepted version
Date
2019-02-05
Authors
Singh, Raghvendra Pratap
Hidalgo, Tania
Cazade, Pierre-Andre
Darcy, Raphael
Cronin, Michael F.
Dorin, Irina
O'Driscoll, Caitríona M.
Thompson, Damien
Journal Title
Journal ISSN
Volume Title
Publisher
American Chemical Society, ACS
Published Version
Abstract
Functionalised cyclodextrin molecules assemble into a wide variety of superstructures in solution, which are of interest for drug delivery and other nanomaterial and biomaterial applications. Here we use a combined simulation and experimental approach to probe the co-assembly of siRNA and cationic cyclodextrin (c-CD) derivatives into a highly stable gene delivery nanostructure. The c-CD form supramolecular structures via interdigitation of their aliphatic tails, analogous to the formation of lipid bilayers and micelles. The native conformation of siRNA is preserved by the encapsulating c-CD superstructure in an extensive hydrogen bonding network between the positively charged sidearms of c-CD and the negatively charged siRNA backbone. The stability of the complexation is confirmed using isothermal titration calorimetry, and the experimental/simulation co-design methodology opens new avenues for creation of highly-engineerable gene delivery vectors.
Description
Keywords
siRNA , Gene delivery , Cyclodextrin , Self-assembly , Molecular dynamics
Citation
Singh, R. P., Hidalgo, T., Cazade, P.-A., Darcy, R., Cronin, M., Dorin, I., O'Driscoll, C. M. and Thompson, D. (2019) 'Self-assembled cationic β-cyclodextrin nanostructures for siRNA delivery', Molecular Pharmaceutics, In Press, doi: 10.1021/acs.molpharmaceut.8b01307
Collections
Copyright
© American Chemical Society. This document is the Accepted Manuscript version of a Published Work that appeared in final form in Molecular Pharmaceutics, copyright © American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.8b01307